Real-world data presented at #ASCO26 by Dr Paulus suggests that GLP-1 therapies may be linked to improved OS in cancer pts. Findings support further research into potential impact of GLP-1 agonists on cancer outcomes. Watch now ▶️ ecancer.org/en/video/129...
At ASCO 2026, ecancer talks to Dr Jessica Paulus about real-world data evaluating GLP-1 receptor agonist use in patients with cancer treated within a large US o
